Paper884384
Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
Eakins KE and 1 other. Br J Pharmacol, 1977. Cited by 21 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. Papers, record 884384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/884384
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
- PubMed
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arachidonic Acids | Major topic |
| Hydroxy Acids | Major topic |
| Indomethacin | Major topic |
| Organophosphorus Compounds | Major topic |
| Prostaglandin Antagonists | Major topic |
| Prostaglandins | Major topic |
| Pyrans | Major topic |
| Animals | |
| Arteries | |
| Biological Assay | |
| Blood Platelets | |
| Depression, Chemical | |
| Dogs | |
| Female | |
| Humans | |
| In Vitro Techniques | |
| Kidney Medulla | |
| Male | |
| Microsomes | |
| Muscle Contraction | |
| Muscle, Smooth | |
| Organophosphonates | |
| Peroxides | |
| Prostaglandins E | |
| Rabbits | |
| Seminal Vesicles | |
| Sheep |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 5,656,636 | Prostaglandins released by the spleen. | Nature | 1968 | https://conductscience.org/library/papers/5656636 | PubMed |
| 3 | 831,285 | Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. | Science | 1977 | https://conductscience.org/library/papers/831285 | PubMed |
| 4 | 1,033,661 | Novel transformations of prostaglandin endoperoxides: formation of thromboxanes. | Adv Prostaglandin Thromboxane Res | 1976 | https://conductscience.org/library/papers/1033661 | PubMed |
| 5 | 990,588 | Prostaglandin antagonism by sodium p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenylpropyl]pheenyl phosphonate (N-0164). | Br J Pharmacol | 1976 | https://conductscience.org/library/papers/990588 | PubMed |
| 6 | 968,059 | N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes. | Prostaglandins | 1976 | https://conductscience.org/library/papers/968059 | PubMed |
| 7 | 968,049 | Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. | Prostaglandins | 1976 | https://conductscience.org/library/papers/968049 | PubMed |
| 8 | 968,048 | Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition. | Prostaglandins | 1976 | https://conductscience.org/library/papers/968048 | PubMed |
| 9 | 5,284,360 | Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. | Nat New Biol | 1971 | https://conductscience.org/library/papers/5284360 | PubMed |
| 10 | 4,389,381 | Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. | Nature | 1969 | https://conductscience.org/library/papers/4389381 | PubMed |
| 11 | 4,514,999 | Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4514999 | PubMed |
| 12 | 959,827 | Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. | Science | 1976 | https://conductscience.org/library/papers/959827 | PubMed |
| 13 | 945,611 | Thromboxanes: selective biosynthesis and distinct biological properties. | Science | 1976 | https://conductscience.org/library/papers/945611 | PubMed |
| 14 | 1,059,088 | Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1059088 | PubMed |
| 15 | 934,294 | Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. | Nature | 1976 | https://conductscience.org/library/papers/934294 | PubMed |
| 16 | 944,058 | Proceedings: Formation of prostaglandin endoperoxides and rabbit aorta contracting substance (RCS) by coupling two enzyme systems. | Br J Pharmacol | 1976 | https://conductscience.org/library/papers/944058 | PubMed |
| 17 | 5,114,995 | Mechanism of prostaglandin biosynthesis. I. Characterization and assay of bovine prostaglandin synthetase. | Biochemistry | 1971 | https://conductscience.org/library/papers/5114995 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 6,781,572 | Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/6781572 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/884384
GET https://conductscience.org/api/papers/v1/884384/authors